These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas. Komminoth P. Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671 [Abstract] [Full Text] [Related]
7. Familial isolated hyperparathyroidism caused by single adenoma: a distinct entity different from multiple endocrine neoplasia. Watanabe T, Tsukamoto F, Shimizu T, Sugimoto T, Taguchi T, Nishisho I, Nakazawa H, Shiba E, Shishiba Y, Takai S. Endocr J; 1998 Oct; 45(5):637-46. PubMed ID: 10395244 [Abstract] [Full Text] [Related]
8. Obvious mRNA and protein expression but absence of mutations of the RET proto-oncogene in parathyroid tumors. Kimura T, Yoshimoto K, Tanaka C, Ohkura T, Iwahana H, Miyauchi A, Sano T, Itakura M. Eur J Endocrinol; 1996 Mar; 134(3):314-9. PubMed ID: 8616528 [Abstract] [Full Text] [Related]
10. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)". Fink M, Weinhüsel A, Niederle B, Haas OA. Int J Cancer; 1996 Aug 22; 69(4):312-6. PubMed ID: 8797874 [Abstract] [Full Text] [Related]
11. Analysis of the RET proto-oncogene in sporadic parathyroid adenomas. Williams GH, Rooney S, Carss A, Cummins G, Thomas GA, Williams ED. J Pathol; 1996 Oct 22; 180(2):138-41. PubMed ID: 8976870 [Abstract] [Full Text] [Related]